TBC1D20

Chr 20AR

TBC1 domain family member 20

Also known as: C20orf140, WARBM4

This gene encodes a protein that belongs to a family of GTPase activator proteins of Rab-like small GTPases. The encoded protein and its cognate GTPase, Rab1, bind the nonstructural protein 5A (NS5A) of the hepatitis C virus (HCV) to mediate viral replication. Depletion of this protein inhibits replication of the virus and HCV infection. Mutations in this gene are associated with Warburg micro syndrome 4. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]

OMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 0.361 OMIM phenotype
Clinical SummaryTBC1D20
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.93). One damaged copy is likely sufficient to cause disease.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.36LOEUF
pLI 0.931
Z-score 3.41
OE 0.12 (0.050.36)
Highly constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
1.21Z-score
OE missense 0.77 (0.680.88)
176 obs / 227.6 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.12 (0.050.36)
00.351.4
Missense OE?0.77 (0.680.88)
00.61.4
Synonymous OE?0.90
01.21.6
LoF obs/exp: 2 / 17.3Missense obs/exp: 176 / 227.6Syn Z: 0.74

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

TBC1D20 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →